These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4420786)

  • 1. Further evidence on the direct action of L-Dopa on prolactin release.
    Donoso AO; Banzán AM; Barcaglioni JC
    Neuroendocrinology; 1974; 15(3-4):236-9. PubMed ID: 4420786
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the dopa decarboxylase inhibitor MK-486 on L-dopa-induced inhibition of prolactin secretion: evidence for CNS participation in the L-dopa effects.
    Szabo M; Nakawatase C; Kovathana N; Frohman LA
    Neuroendocrinology; 1977; 24(1):24-34. PubMed ID: 600362
    [No Abstract]   [Full Text] [Related]  

  • 3. L-3,4-dihydroxyphenylalanine (L-dopa) as an inhibitor of prolactin release.
    Jimenez AE; Voogt JL; Carr LA
    Endocrinology; 1978 Jan; 102(1):166-74. PubMed ID: 743945
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbidopa plus L-dopa pretreatment inhibits the prolactin (PRL) response to thyrotropin-releasing hormone and thus cannot distinguish central from pituitary sites of prolactin stimulation.
    Carlson HE
    J Clin Endocrinol Metab; 1986 Jul; 63(1):249-51. PubMed ID: 3086358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hypothalamic dopamine (DA) on salsolinol (SAL)-induced prolactin (PRL) secretion in male goats.
    Jin J; Hara S; Sawai K; Fülöp F; Nagy GM; Hashizume T
    Anim Sci J; 2014 Apr; 85(4):461-7. PubMed ID: 24329779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hypothalamic dopamine on growth hormone-releasing hormone-induced growth hormone secretion and thyrotropin-releasing hormone-induced prolactin secretion in goats.
    Jin J; Hashizume T
    Anim Sci J; 2015 Jun; 86(6):634-40. PubMed ID: 25442325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of prolactin and growth hormone secretion. Site and mechanism of action of thyrotropin-releasing hormone, L-dopa and L-5-hydroxytryptophan in unanesthetized dogs.
    Richards GE; Holland FJ; Aubert ML; Ganong WF; Kaplan SL; Grumbach MM
    Neuroendocrinology; 1980; 30(3):139-43. PubMed ID: 6767993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-DOPA and the control of prolactin secretion.
    Frantz AG; Suh HK
    Adv Neurol; 1974; 5():447-56. PubMed ID: 4216257
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolactin secretion in Parkinson disease.
    Eisler T; Thorner MO; MacLeod RM; Kaiser DL; Calne DB
    Neurology; 1981 Oct; 31(10):1356-9. PubMed ID: 6810204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Dopa inhibits prolactin secretion in proestrous rats.
    Wiggins JF; Fernstrom JD
    Endocrinology; 1977 Aug; 101(2):469-74. PubMed ID: 560295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of experimentally induced hyperprolactinemia on growth hormone secretion.
    Esquifino AI; Fernández-Ruiz JJ; Cebeira M; Agrasal C; Tresguerres JA; Ramos JA
    Rev Esp Fisiol; 1987 Dec; 43(4):463-8. PubMed ID: 3448711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO; Stoa RF; Thorsen T; Aarskog D
    Acta Paediatr Scand; 1977 Jan; 66(1):81-4. PubMed ID: 831384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric measurement of catecholamine turnover in rat hypothalamus after long-term L-dopa infusion.
    Freed CR; Murphy RC
    J Pharmacol Exp Ther; 1978 Jun; 205(3):702-9. PubMed ID: 660538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of catecholamines in the release of anterior pituitary prolactin in vitro.
    Shaar CJ; Clemens JA
    Endocrinology; 1974 Nov; 95(5):1202-12. PubMed ID: 4609752
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
    Ogawa A; Kanazawa M; Takayanagi M; Kitani Y; Shintaku H; Kohno Y
    Brain Dev; 2008 Jan; 30(1):82-5. PubMed ID: 17590551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dopamine infusion on plasma prolactin released by kidney capsule transplanted anterior pituitaries.
    Chodoroff B; Chodoroff G; Gala RR
    Experientia; 1977 Jun; 33(6):773-4. PubMed ID: 891746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.
    Molitch ME; Goodman RH; Post KD; Biller BJ; Moses AC; King LW; Feldman ZT; Reichlin S
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1118-23. PubMed ID: 7130339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of carbidopa and L-dopa to suppress the prolactin stimulating effect of sulpiride in normal man.
    Zanoboni A; Zanoboni-Muciaccia W; Gattei G; Crespi R
    Farmaco Prat; 1980 Oct; 35(10):510-5. PubMed ID: 7449936
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of hypophysectomy and subsequent prolactin replacement or of elevated prolactin alone on median eminence noradrenaline and dopamine in the rat.
    Morgan WW; Herbert DC; Pfeil KA
    Endocrinology; 1982 May; 110(5):1584-91. PubMed ID: 7075532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.